ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 66.31

Change

-0.41 (-0.61)%

Market Cap

CAD 0.22B

Volume

2.85K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-1.08 (-2.40%)

CAD 3.50B
ZWU:CA BMO Covered Call Utilities ETF

+0.05 (+0.46%)

CAD 1.80B
XIT:CA iShares S&P/TSX Capped Informa..

-2.48 (-3.50%)

CAD 0.89B
TXF:CA First Asset Tech Giants Covere..

-0.43 (-2.10%)

CAD 0.67B
HTA:CA Harvest Tech Achievers Growth ..

-0.44 (-2.46%)

CAD 0.67B
XHC:CA iShares Global Healthcare (CAD..

+0.01 (+0.01%)

CAD 0.56B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.08 (-0.35%)

CAD 0.49B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.01 (+0.04%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

+0.12 (+0.20%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

-1.03 (-1.54%)

CAD 0.26B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.91% 46% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.91% 46% F 44% F
Trailing 12 Months  
Capital Gain -6.63% 17% F 16% F
Dividend Return 0.69% 28% F 8% B-
Total Return -5.95% 9% A- 14% F
Trailing 5 Years  
Capital Gain 10.98% 34% F 44% F
Dividend Return 2.78% 18% F 4% F
Total Return 13.76% 17% F 30% F
Average Annual (5 Year Horizon)  
Capital Gain 2.83% 31% F 42% F
Dividend Return 3.24% 17% F 36% F
Total Return 0.41% 26% F 23% F
Risk Return Profile  
Volatility (Standard Deviation) 15.53% 66% D+ 54% F
Risk Adjusted Return 20.87% 17% F 34% F
Market Capitalization 0.22B 65% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.